FCS

FDA Advisory Committee Votes in Favor of Waylivra for Treatment of Familial Chylomicronemia Syndrome
CP Wire
Fri, 05/11/18 - 10:09 am
Akcea Therapeutics
Ionis Pharmaceuticals
FDA
advisory panel
Waylivra
Volanesorsen
FCS